James Cm Chan1, Jonathan I Scheinman, Karl S Roth
1Professor of Pediatrics, University of Vermont and Director of Research, The Barbara Bush Children's Hospital, Maine Medical Center, Portland, Maine, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
New molecular therapies require trained researchers for clinical trials. Developing molecular markers is crucial for studying pediatric kidney disease progression and treatment effectiveness.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: